{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:44:50Z","timestamp":1791315890516,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11239-014-1164-4","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T12:36:55Z","timestamp":1421757415000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment"],"prefix":"10.1007","volume":"39","author":[{"given":"Charles E.","family":"Mahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"issue":"4","key":"1164_CR1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","volume":"19","author":"G Lu","year":"2013","unstructured":"Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P, Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U (2013) A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med 19(4):446\u2013451. doi: 10.1038\/nm.3102","journal-title":"Nat Med"},{"issue":"18","key":"1164_CR2","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","volume":"121","author":"F Schiele","year":"2013","unstructured":"Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T (2013) A specific antidote for dabigatran: functional and structural characterization. Blood 121(18):3554\u20133562. doi: 10.1182\/blood-2012-11-468207","journal-title":"Blood"},{"issue":"6","key":"1164_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.thromres.2011.03.022","volume":"127","author":"CE Mahan","year":"2011","unstructured":"Mahan CE, Fanikos J (2011) New antithrombotics: the impact on global health care. Thromb Res 127(6):518\u2013524. doi: 10.1016\/j.thromres.2011.03.022","journal-title":"Thromb Res"},{"issue":"2 Suppl","key":"1164_CR4","doi-asserted-by":"crossref","first-page":"e120S","DOI":"10.1378\/chest.11-2294","volume":"141","author":"JI Weitz","year":"2012","unstructured":"Weitz JI, Eikelboom JW, Samama MM, American College of Chest P (2012) New antithrombotic drugs: antithrombotic therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e120S\u2013e151S. doi: 10.1378\/chest.11-2294","journal-title":"Chest"},{"key":"1164_CR5","unstructured":"http:\/\/www.xareltohcp.com\/sites\/default\/files\/pdf\/xarelto_0.pdf-zoom=100 . Xarelto Package Insert. Accessed 12 Feb 2014"},{"key":"1164_CR6","unstructured":"http:\/\/packageinserts.bms.com\/pi\/pi_eliquis.pdf . Eliquis Package Insert. Accessed 12 Feb 2014"},{"key":"1164_CR7","unstructured":"http:\/\/bidocs.boehringer-ingelheim.com\/BIWebAccess\/ViewServlet.ser?docBase=renetnt&folderPath=\/PrescribingInformation\/PIs\/Pradaxa\/Pradaxa.pdf . Pradaxa Package Insert. Accessed 12 Feb 2014"},{"key":"1164_CR8","unstructured":"http:\/\/www.daiichisankyo.com\/media_investors\/media_relations\/press_releases\/detail\/006065.html . Edoxaban FDA submission. Accessed 12 Feb 2014"},{"key":"1164_CR9","unstructured":"http:\/\/www.portola.com\/clinical-development\/andexanet-alfa-prt4445-fxa-inhibitor-antidote\/ . Andexanet Alpha Xa Reversal Agent. Accessed 12 Feb 2014"},{"key":"1164_CR10","unstructured":"http:\/\/www.boehringer-ingelheim.com\/news\/news_releases\/press_releases\/2014\/19_november_2014dabigatranetexilateaha.html . Idarucizumab\u2013Pradaxa Reversal Agent. Accessed 12 Feb 2014"},{"key":"1164_CR11","unstructured":"http:\/\/www.jnj.com\/news\/all\/Janssen-Expands-EXPLORER-Global-Cardiovascular-Research-Program-to-Evaluate-the-Role-of-XARELTO-in-Addressing-Critical-Medical-Needs . Rivaroxaban research programs. Accessed 12 Feb 2014"},{"key":"1164_CR12","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/results?term=apixaban&Search=Search . Apixaban clinical trials. Accessed 12 Feb 2014"},{"key":"1164_CR13","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/results?term=rivaroxaban&Search=Search . Rivaroxaban clinical research. Accessed 12 Feb 2014"},{"issue":"5","key":"1164_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","volume":"15","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P, European Heart Rhythm A (2013) European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15(5):625\u2013651. doi: 10.1093\/europace\/eut083","journal-title":"Europace"},{"issue":"15","key":"1164_CR15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"VTEI Hokusai","year":"2013","unstructured":"Hokusai VTEI, Buller HR, Decousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369(15):1406\u20131415. doi: 10.1056\/NEJMoa1306638","journal-title":"N Engl J Med"},{"issue":"2","key":"1164_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5853\/jos.2014.16.2.73","volume":"16","author":"OY Bang","year":"2014","unstructured":"Bang OY, Hong KS, Heo JH, Koo J, Kwon SU, Yu KH, Bae HJ, Lee BC, Yoon BW, Kim JS (2014) New oral anticoagulants may be particularly useful for asian stroke patients. J Stroke 16(2):73\u201380. doi: 10.5853\/jos.2014.16.2.73","journal-title":"J Stroke"},{"key":"1164_CR17","unstructured":"Source: IMS Health National Prescription Audit, data through 11\/14\/14. Courtesy Janssen Pharmaceuticals 12\/1\/2014"},{"key":"1164_CR18","unstructured":"http:\/\/www.eliquis.com\/eliquis\/support-coverage-assistance . Apixaban coverage. Accessed 12 March 2014"},{"key":"1164_CR19","unstructured":"http:\/\/www.xareltohcp.com\/formulary-map.html . Xarelto formulary map. Accessed 12 March 2014"},{"key":"1164_CR20","unstructured":"http:\/\/www.xareltohcp.com\/access-affordability\/access-affordability.html . Xarelto Access and Affordability. Accessed 12 March 2014"},{"key":"1164_CR21","unstructured":"http:\/\/www.pradaxapro.com\/pradaxalink\/dabigatran-coverage-affordability . Pradaxa coverage. Accessed 12 March 2014"},{"key":"1164_CR22","unstructured":"http:\/\/www.fingertipformulary.com\/drugs\/Eliquis\/ . Eliquis Coverage by State. Accessed 12 March 2014"},{"key":"1164_CR23","unstructured":"http:\/\/www.xareltocarepath.com\/reducing-stroke-risk\/xarelto-savings-programs . Xarelto savings programs. Accessed 12 March 2014"},{"key":"1164_CR24","unstructured":"http:\/\/www.eliquis.com\/eliquis\/support-offers . Eliquis support programs. Accessed 12 March 2014"},{"key":"1164_CR25","unstructured":"http:\/\/www.pradaxa.com\/patient-support\/pradaxalink.html . Pradaxa support programs. Accessed 12 March 2014"},{"key":"1164_CR26","unstructured":"http:\/\/oig.hhs.gov\/fraud\/docs\/alertsandbulletins\/2014\/SAB_Copayment_Coupons.pdf . Office of inspector general special advisory bulletin. Accessed 12 March 2014"},{"issue":"3","key":"1164_CR27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11239-014-1060-y","volume":"37","author":"E Abo-Salem","year":"2014","unstructured":"Abo-Salem E, Becker R (2014) Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians. J Thromb Thrombolysis 37(3):372\u2013379. doi: 10.1007\/s11239-014-1060-y","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"1164_CR28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1076029611416642","volume":"18","author":"JK Atay","year":"2012","unstructured":"Atay JK, Fiumara K, Piazza G, Fanikos J, Goldhaber SZ (2012) Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service. Clin Appl Thromb\/Hemost 18(2):181\u2013184. doi: 10.1177\/1076029611416642","journal-title":"Clin Appl Thromb\/Hemost"},{"issue":"2 Suppl","key":"1164_CR29","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R, College American, Chest P (2012) Perioperative management of antithrombotic therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e326S\u2013e350S. doi: 10.1378\/chest.11-2298","journal-title":"Chest"},{"issue":"22","key":"1164_CR30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, Investigators EA-T (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093\u20132104. doi: 10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"issue":"5","key":"1164_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0049-3848(86)90169-6","volume":"44","author":"J Dawes","year":"1986","unstructured":"Dawes J, Prowse CV, Pepper DS (1986) Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Thromb Res 44(5):683\u2013693","journal-title":"Thromb Res"},{"issue":"2","key":"1164_CR32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1160\/TH12-03-0162","volume":"108","author":"CE Mahan","year":"2012","unstructured":"Mahan CE, Borrego ME, Woersching AL, Federici R, Downey R, Tiongson J, Bieniarz MC, Cavanaugh BJ, Spyropoulos AC (2012) Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost 108(2):291\u2013302. doi: 10.1160\/TH12-03-0162","journal-title":"Thromb Haemost"},{"key":"1164_CR33","unstructured":"http:\/\/www.health.gov\/hai\/prevent_hai.asp . Nosocomial infections. Accessed 12 May 2014"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-014-1164-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1164-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:02:07Z","timestamp":1559386927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-014-1164-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s11239-014-1164-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}